Early Lung Cancer: What You Should Know

Early lung cancer is cancer that is confined to the lung or nearby tissues, according to the findings used for staging. Some people are diagnosed after a scan for another reason, while others notice a cough that does not settle, breathlessness, chest discomfort, coughing blood, repeated chest infections, unexplained weight change, or a hoarse voice. These symptoms have many possible causes; a hoarse voice can have causes unrelated to cancer, so it should be assessed in context.

Diagnosis commonly involves imaging and a sample of tissue or cells when appropriate. Staging looks at the tumour, nearby lymph nodes, and whether disease is present elsewhere, including the brain. Genomic tumour profiling may identify features that help the team discuss treatment choices.

Arrange a clinical assessment for a new or persistent respiratory change, especially if you smoke now or smoked in the past. Bring a list of symptoms, medicines, previous scans, and relevant family or occupational history. A clinician may listen to your chest, request imaging, and refer you to a specialist; further tests depend on the findings.

Treatment is selected by stage, tumour type, overall health, and personal preferences. Options may include lung lobectomy or another operation, radiotherapy, chemotherapy, or a combination. Genomic results can add information when systemic treatment is being considered. Palliative care can also support symptoms and quality of life at any stage and may be provided alongside cancer treatment.

Book a medical appointment for a cough, breathlessness, chest pain, repeated infections, unexplained weight change, or hoarseness that persists or worsens. Seek urgent help for severe difficulty breathing, coughing a large amount of blood, sudden chest pain, fainting, or new confusion. These warning signs need prompt attention regardless of their cause.

Ask which tests are needed, what the scan shows, whether a tissue sample is recommended, and how staging will be confirmed. You can also ask whether genomic tumour profiling is useful, which treatments fit the findings, how an operation or radiotherapy could affect breathing, and how symptoms will be supported during treatment.